Reading about the CJC-1295 / ipamorelin blend? The 10 mg vial with a per-lot certificate:See it at OXpeptides (research use only)
Editorial policyin force since September 21, 2026

Editorial policy for cjc-1295-ipamorelin.com

Nine rules, applied to every page. They are short because they are meant to be checked, not admired.

The nine rules at a glance

Sources

A claim about what a peptide does in a living organism is supported by a peer-reviewed publication or a registered clinical trial, cited on the same page. Every DOI is verified on the CrossRef API and every NCT number on the ClinicalTrials.gov API before publication; a reference that does not resolve is not used. Regulatory statements cite the agency page they come from. Secondary sources (clinic pages, forums, supplier pages, encyclopaedias) are never cited as evidence.

Numbers

A number is quoted as the source states it, in the source's units, with the population and the duration it applies to. Fold-changes, percentages and half-lives are never rounded into stronger claims. Search volumes quoted on the site are monthly United States figures from Google Ads data, measured in September 2026; where Google Ads returns no figure for a term, the site says so.

Doses

Doses appear only as the doses of the studies cited, with the route, schedule, population and DOI. They are reported, not recommended. The site publishes no protocol and no dose for the CJC-1295 ipamorelin combination, because no published study has administered it.

Effects

The site does not describe effects that no human study has measured for these molecules. Muscle, fat, sleep, recovery, anti-aging and similar outcomes are named only to say that they have not been studied for CJC-1295 ipamorelin.

Testimonials and reviews

None. The site publishes no personal accounts, no reviews, no ratings, no before-and-after material, and does not invent them.

Status

Every page states that CJC-1295 and ipamorelin are investigational compounds, not approved by the FDA or the EMA, and that the content is informational and not medical advice.

Independence

The site accepts no advertising, no sponsored content and no affiliate commission. It links to one supplier page, chosen by the published criteria in the for-sale guide, and receives nothing for the link. It carries no analytics or tracking script.

Dates

Each article shows the date it was published and the date it was last updated. Sources are re-verified when an article is updated.

Corrections

Errors are corrected on the page, the updated date is changed, and a note is added at the foot of the page when a figure changes. Correction requests go to editor@cjc-1295-ipamorelin.com. A request that cites a DOI or an NCT number is handled first; every request receives an answer.

Read next: about the site and its method, or start with the main article on CJC-1295 ipamorelin.

Informational content, not medical advice. CJC-1295 and ipamorelin are investigational research compounds, not approved by the FDA or the EMA for any use.

See it at OXpeptides (research use only)